Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis

BACKGROUND: Sodium-glucose-cotransporter-2 (SGLT2) inhibitors have proven to be effective in improving glycemic control and lowering body weight in patients with type 2 diabetes mellitus. However, the efficacy and safety on weight loss in adults with overweight or obesity but not diabetes remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hanrui, Liu, Min, Li, Sheyu, Shi, Qingyang, Zhang, Shengzhao, Zhou, Yiling, Su, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415407/
https://www.ncbi.nlm.nih.gov/pubmed/34484120
http://dx.doi.org/10.3389/fendo.2021.706914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415407/
https://www.ncbi.nlm.nih.gov/pubmed/34484120
http://dx.doi.org/10.3389/fendo.2021.706914

Ejemplares similares